XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
CNY (¥)
¥ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
CNY (¥)
¥ / shares
shares
Dec. 31, 2018
CNY (¥)
¥ / shares
shares
Revenues, net of value-added tax ¥ 223,011 $ 34,178 ¥ 198,363 ¥ 190,898
Cost of revenues (209,928) (32,173) (214,193) (171,136)
Gross profit (loss) 13,083 2,005 (15,830) 19,762
Operating expenses:        
Selling expenses (25,761) (3,948) (30,241) (21,718)
General and administrative expenses (294,823) (45,184) (315,134) (291,854)
Impairment of long-lived assets (8,500) (1,303) (76,089) (5,433)
Operating loss (316,001) (48,430) (437,294) (299,243)
Interest expense (including interest expense to related party amounting to RMB193, RMB151 and RMB41,918 (US$6,219) for the years ended December 31, 2018, 2019 and 2020, respectively) (81,359) (12,469) (28,700) (46,232)
Foreign exchange gain (loss) , net (58,686) (8,994) 34,990 36,531
Gain (loss) on disposal of long-lived assets 677 104 (1,299) 4,711
Interest income (including interest income from related party amounting to RMB285, RMB206 and RMB127(US$19) for the years ended December 31, 2018, 2019 and 2020, respectively) 8,440 1,293 9,165 14,168
Income (loss) from equity method investments 6,021 923 (5,078) (20,747)
Gain (loss) on disposal of subsidiaries (14,894) (2,283) 0 3,341
Other income, net 6,312 967 37,138 34,206
Gain on disposal of an equity method investment 7,837 1,201 0 48,019
Loss before income tax (441,653) (67,688) (391,078) (225,246)
Income tax (expenses) benefit 37,624 5,766 38,986 (34,051)
Net loss (404,029) (61,922) (352,092) (259,297)
Net loss attributable to noncontrolling interests 94,040 14,412 45,043 24,422
Net loss attributable to Concord Medical Services Holdings Limited ¥ (309,989) $ (47,510) ¥ (307,049) ¥ (234,875)
Loss per share for Class A and Class B ordinary shares:        
Basic and diluted | (per share) ¥ (5.11) $ (0.78) ¥ (4.24) ¥ (2.76)
Weighted average number of class A and class B ordinary shares outstanding:        
Basic and diluted 131,053,858 131,053,858 130,238,498 130,104,787
Other comprehensive income (loss), net of tax of nil        
Foreign currency translation, net tax of nil ¥ 50,856 $ 7,794 ¥ (8,664) ¥ (41,203)
Total other comprehensive income (loss), net of tax 50,856 7,794 (8,664) (41,203)
Comprehensive loss (353,173) (54,128) (360,756) (300,500)
Comprehensive loss attributable to noncontrolling interests (94,040) (14,412) (43,930) (22,902)
Comprehensive loss attributable to Concord Medical Services Holdings Limited (259,133) (39,716) (316,826) (277,598)
Equipment Leasing Revenues        
Revenues, net of value-added tax 52,906 8,108 58,559 76,723
Cost of revenues (36,911) (5,657) (77,730) (63,125)
Services and other revenues        
Revenues, net of value-added tax 140,050 21,464 117,027 99,117
Cost of revenues (143,443) (21,984) (119,096) (100,232)
Medicine income        
Revenues, net of value-added tax 30,055 4,606 22,777 15,058
Cost of revenues ¥ (29,574) $ (4,532) ¥ (17,367) ¥ (7,779)